Nichi-Iko Pharmaceutical Co., Ltd.

  • Text Size

    • S
    • M
    • L
    • Japanese
    • English

  • About Us
    Corporate Information
    Corporate Information
    What is Premium Quality ?
    What is Premium Quality ?
    The 7th Mid-term Business Plan "Obelisk"
    The 7th Mid-term
    Business Plan "Obelisk"
  • Product Information
    Products in JAPAN
    Products in JAPAN
    Products in ASIA
    Products in ASIA
  • Investor Relations
    IR News
    IR News
    Management Vision
    Management Vision
    Highlights of Financial Results
    Highlights of Financial Results
    IR Information Office
    IR Information Office
    Shareholder / Share Information
    Shareholder /
    Share Information
     IR Calendar
    IR Calendar
    Shared Research Report
    Shared Research Report
    • Risk Information
    • Disclaimers
    • IR Inquiry
  • CSR
    Basic Policy
    Basic Policy
    Ecology
    Ecology
    Community
    Community
    Human Rights
    Human Rights
Nichi-Iko Pharmaceutical Co., Ltd.

  • About Us
  • Product Information
  • Investor Relations
  • CSR
  • Japanese
  • English

COMPANYAbout Us

GENERICProduct Information

IRInvestor Relations

CORPORATE SOCIAL RESPONSIBILITYCSR

INFORMATION

    • 02/12/2019
      PRESS RELEASE
      Consolidated Financial Results for the third Quarter of the Fiscal Year Ending March 31, 2019 (IFRS)
    • 12/05/2018
      PRESS RELEASE
      Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2019 (IFRS)
    • 11/09/2018
      PRESS RELEASE
      FY2019/3 H1, Presentaion (Apr.1 to Sep.30 2018)
    • 11/09/2018
      PRESS RELEASE
      FY2019/3 H1, Supplementary Material(Apr.1 to Sep.30 2018)
    • 08/30/2018
      PRESS RELEASE
      Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March, 2019
READ MORE
  • Head Quarters
  • R&D Sites
  • Production Sites
  • Distribution Centers
  • Branch Offices
  • Subsidiaries
  • SAGENT Pharmaceuticals
  • Nichi-iko(Thailand)
  • スタジー Stu-GE
  • ONCOLOGY MedNavi
  • SAGENT Pharmaceuticals
  • Nichi-iko(Thailand)
  • スタジー Stu-GE
  • ONCOLOGY MedNavi
PAGETOP
  • About Us
    • Corporate Information
      • Corporate Profile
      • Company Brochure(PDF)
      • Corporate History
      • Organization
      • Offices
    • What is Premium Quality ?
      • Development Structure
      • Production Structure
      • Distribution Structure
      • Quality Assurance Structure
      • Information Provision Structure
    • The 7th Mid-term
      Business Plan "Obelisk"
  • Product Information
    • Products in JAPAN
      • Oral Drugs Design
      • Packagings Design
      • External Drugs Design
      • A-Z List of Our Products /
        Kusuri-no-Shiori®
    • Products in ASIA
      • Hong Kong
      • Thailand
      • Malaysia
      • Vietnam
      • Philippines
      • Singapore
  • Investor Relations
    • IR News
    • Management Vision
    • Highlights of Financial Results
    • IR Information Office
    • Shareholder / Share Information
    • IR Calendar
    • Shared Research Report
    • Risk Information
    • Disclaimers
    • IR Inquiry
  • CSR
    • Basic Policy
    • Ecology
    • Community
    • Human Rights
  • Site Map

Copyright 2018 Nichi-Iko Pharmaceutical Co., Ltd. All Rights Reserved.